Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

NCT05789615 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

CMV Infection
Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Letermovir

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]